BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...

For more than half a century, particle physicists have theorized the existence of a “glueball,” a particle made entirely of gluons. While the past few decades have produced some compelling candidates, ...

CLEVELAND, January 9, 2019 - The Lubrizol Corporation announces its contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has strengthened its ...

A particle accelerator that produces intense X-rays could be squeezed into a device that fits on a table, my colleagues and I have found in a new research project. The way that intense X-rays are ...

BETHLEHEM, Pa., April 6, 2015 /PRNewswire/ -- Particle Sciences, a leading drug delivery CDMO, has received a Notice of Allowance for composition and use of the technology incorporated into its SATx™ ...

The next head of Europe's CERN physics laboratory said Thursday that he favored moving forward with plans for a giant particle collider far more powerful than the collider that discovered the famous ...

WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine presents an ambitious and comprehensive long-term vision for the field of particle physics to further our ...

If particle physicists get their way, new accelerators could one day scrutinize the most tantalizing subatomic particle in physics — the Higgs boson. Six years after the particle’s discovery at the ...